Bringing brilliant ideas to life - and to market

UCL’s truly exceptional research deserves a chance to change the world, with the expert support to make it happen.

Science teamwork, tablet and scientist in digital research analysis, investigation or check medical software analytics in laboratory. Healthcare innovation biotechnology expert people reading report stock photo

198

companies since 1993

£4.5bn

capital raised since 2016

1400+

patents filed since 1993

8700+

licences since 1993

Working side by side with UCL academics

As UCL’s expert commercialisation partner, we provide tailored support and specialist expertise to help researchers, clinicians and academics take ideas and technologies beyond the university.

UCL Ventures helps make your idea market-ready with expert advice, strategic commercial insight, and practical support to help realise the full commercial and social value of your research.

Curious about taking your research to market?

Whether you’re at the earliest stage of an idea and want to understand its commercial viability, or preparing to launch a spinout, a serial academic entrepreneur or simply dipping your toe into the commercial world, we guide you carefully and collaboratively.

Commercialisation can feel unfamiliar, so we’ve broken down how it works:

How we work with you What you can expect

There are multiple routes to take your research to market - explore them here:

Create a company License your invention Routes to social impact Protect your idea

Ways we can support you on your journey to market:

Helpful tools & resources Common questions Inspiring stories

30 years' experience

UCL Ventures: a powerhouse of commercialisation

Based in Bloomsbury, at the heart of London’s innovation ecosystem, UCL Ventures brings specialist commercial, scientific and investment expertise to every stage of the journey from invention to market.

We harness UCL’s innovations to deliver substantial impact, strong investor returns, and high‑quality ventures shaping the future.

Learn more about UCL Ventures

Explore our portfolio

Our extensive portfolio of spinouts and technologies spans departments, disciplines and sectors.

Gigaton

Energy & cleantech

Gigaton

Mission to reduce global emissions at gigatonne scale.

Endomag

Experienced radiologic technologist preparing female patient for mammogram

Oncology, Medtech

Endomag

Medical devices for surgical guidance in breast cancer and more.

Autolus Therapeutics

Drug discovery, Oncology

Autolus Therapeutics

Developing next-generation programmed T-cell therapies for cancer.

"Time was of the essence"

UCL Ventures recognised that time was of the essence. Their team really cared about our story, and what it meant for us to spin out, and I will never forget that.

Dr Maria Leiloglou, CEO and founder of Enacuity

"A close relationship"

The close relationship between Autolus and UCL Ventures has spanned more than a decade; UCL Ventures helped establish the company in 2014.

Dr Martin Pule, Founder and Chief Scientific Officer of Autolus Therapeutics

Inspiring stories

How UCL research is changing lives, businesses and communities.

View case studies

Endomag: reducing breast cancer diagnostic pain and improving access

Real-world impact

Endomag: reducing breast cancer diagnostic pain and improving access

By removing the use of radioactive tracers, more women can access diagnostics.

Senceive: protecting people and infrastructure through real-time monitoring technology

Real-world impact

Senceive: protecting people and infrastructure through real-time monitoring technology

Enabling precise and reliable monitoring for challenging applications, providing customers with repeatable, high-quality asset performance data.

TrimTots: fun family workshops enabling healthier lifestyle choices

two mothers and their toddler children at a table eating food

Social Ventures

TrimTots: fun family workshops enabling healthier lifestyle choices

Educating families with proven methods to reduce childhood obesity.

News & views

Navigate to UCL recognised for its leading IP commercialisation in KEF 2026

UCL news

UCL recognised for its leading IP commercialisation in KEF 2026

UCL has once again been recognised as one of the UK's leading universities for 'knowledge exchange' - the process of taking ideas research and innovations beyond academia and out to the world - and has achieved the highest rating for intellectual property and commercialisation in this year's Knowledge Exchange Framework (KEF).

7 October 2026